Onglyza Lawsuit Alleges Woman Died Of Heart Failure After Taking Diabetes Drug

Print

Wright & Schulte Is Investigating Onglyza Lawsuit Claims Alleging AstraZeneca’s Type 2 Diabetes Drugs May Cause Heart Failure and Pancreatic Cancer.

onglyza-kombiglyze-lawsuit-Side-Effects-Lawyer-A recent Onglyza lawsuit filed against against the drug’s manufacturer, AstraZeneca claims the type 2 diabetes AstraZeneca caused the death of a Chicago woman in October 2013. Onglyza and Kombiglyze XR are new generation diabetes drugs that are the subjects of Onglyza lawsuits alleging the prescription medications can cause heart failure, pancreatitis, pancreatic cancer, thyroid cancer and other health complications.

The Onglyza wrongful death lawsuit claim, which was filed by the woman’s daughter, said the woman was prescribed Onglyza in 2010 to treat type 2 diabetes. The following year, the woman suffered a heart attack and was hospitalized. In 2013, the woman was hospitalized twice before she died in October. The Onglyza lawsuit contends that London-based AstraZeneca Pharmaceuticals LP was negligent because it failed to warn the public about the health risks associated with its diabetes drug. (Case No. 2015-L-010969, Cook County Circuit Court, Chicago)

The attorneys at Wright & Schulte LLC continue to investigate Onglyza lawsuit claims and has spoken with people who were prescribed the type 2 and suffered heart failure, pancreatitis, pancreatic cancer, thyroid cancer or other serious side effects. To speak with one of the firm’s attorneys, contact Wright & Schulte by visiting www.yourlegalhelp.com or call 1-888-399-0795.

Onglyza (saxagliptin) was approved by the U.S. Food and Drug Administration (FDA) in 2009 and Kombiglyze XR (saxagliptin and metformin hydrochloride extended-release) was approved the following year. The two medications are in a class of drugs called dipeptidyl peptidase-4 (DPP-4) inhibitors which inhibits an enzyme in the body that reduces insulin production. In April 2015, an FDA committee voted in favor of the FDA requiring saxagliptin to carry a warning label about the risk of heart failure after reviewing a study that found a 27 percent increase in the hospitalization rate among patients who were prescribed the drug. One committee member voted to take the drug off the market. The study connecting saxagliptin with heart failure was published in The New England Journal of Medicine in October 2013.
[astrazeneca.com/our-company/media-centre/press-releases/2015/fda-advisory-committee-reviews-saxagliptin-type-2-diabetes-14042015.html, AstraZeneca, April 14, 2015]
[http://www.fda.gov/Drugs/DrugSafety/ucm459579.htm, FDA, August 28, 2015]

The FDA has been investigating Onglyza and Kombiglyze XR since 2013 after the federal agency’s adverse events database showed patients had experienced additional side effects allegedly from taking the drugs. From 2004 to 2009, the FDA received reports of pancreatitis or inflammation of the pancreas, pancreatic cancer and thyroid cancer. By August 2015, the FDA found that severe and disabling joint pain had been associated with DDP-4 inhibitors. According to a review of adverse events reports submitted to the FDA, the pain symptoms started from 1 day to years after they started taking a DPP-4 inhibitor. The pain symptoms went away after patients stopped taking the medication. The federal agency added a warning and precaution about the joint pain risk to the labels of Onglyza and Kombiglyze XR.
[http://www.fda.gov/Drugs/DrugSafety/ucm459579.htm, FDA, August 28, 2015]
[http://www.fda.gov/downloads/Drugs/DrugSafety/UCM280360.pdf, FDA, May 2013]

Onglyza and Kombiglyze XR lawsuits have been filed against AstraZeneca purporting that the company knew about the health risks of its medications but did not warn doctors and their patients about the potential life-threatening side effects.

About Wright & Schulte LLC, an experienced personal injury firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright Schulte LLC stand up for the rights of people who have been injured or wronged, and fight tirelessly to ensure that even the world’s most powerful corporations take responsibility for their actions. If you’re looking for a law firm that will guarantee the aggressive and personal representation you deserve, do not hesitate to contact Wright & Schulte LLC today. Free Onglyza Lawsuit and Kombiglyze XR Lawsuit case evaluations are available through yourlegalhelp.com, or call 1-888-399-0795.

Contact:
Wright & Schulte LLC
865 S. Dixie Dr.
Vandalia, Ohio 45377
1-800-399-0795
http://www.yourlegalhelp.com

This entry was posted in Wright & Schulte Lawsuit News. Bookmark the permalink.